Deadline: February 26, 2024
Applications are open for the Venture Leaders Biotech 2024. The Venture Leaders Biotech program offers entrepreneurs a way to accelerate the growth curve of their startups by taking them to one of the most significant hubs of technological innovation in the life sciences: Boston.
The program, which is free of charge, is a unique opportunity for top Swiss-based biotech startups to assert their presence on the international stage while expanding their U.S. network. For one week in May, the Venture Leaders will have the opportunity to meet with investors and profit from the experience and insights of industry experts, VCs, and peers.
Alumni of the program include Covagen (acquired by Johnson&Johnson), Redbiotec (partly acquired by Pfizer), KB Medical (acquired by Globus Medical), SimplicityBio (acquired by Precision for Medicine), AMAL Therapeutics (acquired by Boehringer Ingelheim) and Interax Biotech (Seed round with US investors met during the roadshow).
Benefits
- Win your place in the Swiss National Startup Team 2024 and meet industry leaders and international biotech investors in Boston.
Eligibility
- Open to founding and managing members of biotech-based Swiss startups;
- Ready to grow your business in the US with international investors;
- Building a global biotech startup;
- Mandatory to be incorporated before the Roadshow starts.
Application
Register your project and apply for one of the 10 seats in the intensive entrepreneurship week training program in global innovation hubs.
For more information, visit Venture Leaders Biotech.
